Ireland amends rules on prescription and supply of medicinal products

The Minister for Health has made new regulations amending how prescription medicines are prescribed and supplied in Ireland, in a change published in the official gazette on Tuesday, 8 September 2026. The instrument, cited as the Medicinal Products (Prescription and Control of Supply) (Amendment) Regulations 2026, appears as S.I. No. 457 of 2026 in Iris Oifigiúil.

The regulations were made by the Minister for Health in exercise of the powers conferred by section 32 of the Irish Medicines Board Act 1995 (No. 29 of 1995). The gazette notice confirms the instrument amends the existing Medicinal Products (Prescription and Control of Supply) Regulations, which govern the conditions under which prescription-only medicines may be prescribed and dispensed.

Legal basis and scope

The amendment is anchored in the Irish Medicines Board Act 1995, the primary legislation that established the framework for the regulation of medicinal products in the State. Section 32 of that Act empowers the Minister for Health to make regulations governing the prescription and control of supply of medicinal products.

The new instrument updates that framework, and its practical effect will be felt across the medicines supply chain:

• Pharmacists, who dispense prescription medicines and must comply with the conditions of supply;
• Prescribers, including doctors and other authorised health professionals who issue prescriptions;
• Patients, who receive medicines under the revised rules.

Publication and availability

The regulations were published in Iris Oifigiúil, Number 72, dated Tuesday, 8 September 2026, in Section I. Copies may be purchased from Government Publications, Mountshannon Road, Kilmainham, Dublin, D08 XA06, by phone at 046 942 3100, or by email at publications@opw.ie. The price of the instrument is €3.50.

The gazette entry records the making of the regulations and their citation, and directs readers to the official publication for the full text of the amendments.

What it means

Because the instrument amends the core rules on prescription and control of supply, it directly affects the day-to-day operation of pharmacies and the obligations of prescribers across the State. For patients, any change to the conditions under which medicines are prescribed and supplied can alter how and when they access treatment.

The publication of S.I. No. 457 of 2026 signals a routine but consequential update to Irish medicines law, and those working in the sector should consult the full text of the regulations to understand the precise changes now in force.

Source: Iris Oifigiúil, No. 72, 8 September 2026, Section I, p. (official reference: S.I. No. 457 of 2026).